Page 85 - BH-2-3

Brain & Heart Lipids in ALS: Bad and beneficial

28. Schrödinger. What Do All the Prime MM-GBSA Energy 39. Parrella E, Porrini V, Scambi I, et al. Synergistic association
Properties Mean ? 2019. Available from: https://www. of resveratrol and histone deacetylase inhibitors as
schrodinger.com/kb/1875 [Last accessed on 2023 Nov 20]. treatment in amyotrophic lateral sclerosis. Front Pharmacol.
2022;13:1017364.
29. Novak V, Rogelj B, Župunski V. Therapeutic potential
of polyphenols in amyotrophic lateral sclerosis and doi: 10.3389/fphar.2022.1017364
frontotemporal dementia. Antioxidants (Basel). 40. Peterson GM, Naunton M. Valproate: A simple chemical
2021;10(8):1328.
with so much to offer. J Clin Pharm Ther. 2005;30(5):417-421.
doi: 10.3390/antiox10081328
doi: 10.1111/j.1365-2710.2005.00671.x
30. Carrera-Juliá S, Moreno ML, Barrios C, de la Rubia Ortí JE,
Drehmer E. Antioxidant alternatives in the treatment of 41. Crochemore C, Virgili M, Bonamassa B, et al. Long-term
amyotrophic lateral sclerosis: A comprehensive review. Front dietary administration of valproic acid does not affect,
while retinoic acid decreases, the lifespan of G93A mice,
Physiol. 2020;11:63.
a model for amyotrophic lateral sclerosis. Muscle Nerve.
doi: 10.3389/fphys.2020.00063 2009;39(4):548-552.
31. Bono S, Feligioni M, Corbo M. Impaired antioxidant doi: 10.1002/mus.21260
KEAP1-NRF2 system in amyotrophic lateral sclerosis:
NRF2 activation as a potential therapeutic strategy. Mol 42. Bang WS, Kim KT, Cho DC, Kim HJ, Sung JK. Valproic Acid
Neurodegen. 2021;16:71. increases expression of neuronal stem/progenitor cell in
spinal cord injury. J Korean Neurosurg Soc. 2013;54(1):8-13.
doi: 10.1186/s13024-021-00479-8
doi: 10.3340/jkns.2013.54.1.8
32. Pedersen WA, Cashman NR, Mattson MP. The lipid
peroxidation product 4-hydroxynonenal impairs glutamate 43. Zhu MM, Li HL, Shi LH, Chen XP, Luo J, Zhang ZL. The
and glucose transport and choline acetyltransferase activity pharmacogenomics of valproic acid. J Human Genet.
in NSC-19 motor neuron cells. Exp Neurol. 1999;155(1):1-10. 2017;62(12):1009-1014.
doi: 10.1006/exnr.1998.6890 doi: 10.1038/jhg.2017.91
33. Banerjee P, Eckert AO, Schrey AK, Preissner R. ProTox-II: A 44. Smith RG, Henry YK, Mattson MP, Appel SH. Presence
webserver for the prediction of toxicity of chemicals. Nucleic of 4-hydroxynonenal in cerebrospinal fluid of patients
Acids Res. 2018;46(W1):W257-W263. with sporadic amyotrophic lateral sclerosis. Ann Neurol.
1998;44(4):696-699.
doi: 10.1093/nar/gky318
doi: 10.1002/ana.410440419
34. Tellone E, Galtieri A, Russo A, Giardina B, Ficarra S.
Resveratrol: A focus on several neurodegenerative diseases. 45. Pedersen WA, Fu W, Keller JN, et al. Protein modification
Oxid Med Cell Longev. 2015;2015:392169. by the lipid peroxidation product 4-hydroxynonenal in the
spinal cords of amyotrophic lateral sclerosis patients. Ann
doi: 10.1155/2015/392169 Neurol. 1998;44(5):819-824.
35. Han S, Choi JR, Soon Shin K, Kang SJ. Resveratrol doi: 10.1002/ana.410440518
upregulated heat shock proteins and extended the survival
of G93A-SOD1 mice. Brain Res. 2012;1483:112-117. 46. Benedusi V, Martorana F, Brambilla L, Maggi A, Rossi D.
The peroxisome proliferator-activated receptor γ (PPARγ)
doi: 10.1016/j.brainres.2012.09.022 controls natural protective mechanisms against lipid
36. Mancuso R, del Valle J, Modol L, et al. Resveratrol improves peroxidation in amyotrophic lateral sclerosis. J Biol Chem.
motoneuron function and extends survival in SOD1(G93A) 2012;287(43):35899-35911.
ALS mice. Neurotherapeutics. 2014;11(2):419-432. doi: 10.1074/jbc.M112.366419
doi: 10.1007/s13311-013-0253-y 47. Siow RC, Ishii T, Mann GE. Modulation of antioxidant
37. Andrade S, Ramalho MJ, Pereira, MC, Loureiro JA. gene expression by 4-hydroxynonenal: Atheroprotective
Resveratrol brain delivery for neurological disorders role of the Nrf2/ARE transcription pathway. Redox
prevention and treatment. Front Pharmacol. 2018;9:1261. Rep. 2007;12(1):11-15.
doi: 10.3389/fphar.2018.01261 doi: 10.1179/135100007X162167
38. Nagy JA, Semple C, Lo P, Rutkove SB. Assessing the 48. Milkovic L, Zarkovic N, Marusic Z, Zarkovic K, Jaganjac M.
therapeutic impact of resveratrol in ALS SOD1-G93A The 4-hydroxynonenal-protein adducts and their biological
mice with electrical impedance myography. Front Neurol. relevance: Are some proteins preferred targets? Antioxidants
2022;13:1059743. (Basel). 2023;12:856.
doi: 10.3389/fneur.2022.1059743 doi: 10.3390/antiox12040856

Volume 2 Issue 3 (2024) 14 doi: 10.36922/bh.2976